[1]. Rao SV, et al. 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on ...
1.Byrne RA, Rossello X, Coughlan JJ, et al.2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023 Aug 25:ehad191. 2.应用β肾上腺素能受体阻滞剂规范治疗冠心病中国专家共识组. 应用β肾上腺素能...
1.Byrne RA, Rossello X, Coughlan JJ, et al.2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023 Aug 25:ehad191. 2.应用β肾上腺素能受体阻滞剂规范治疗冠心病中国专家共识组. 应用β肾上腺素能受体阻滞剂规范治疗冠心病的中国专家共识. 中国循环杂志. 2020;35(2):108...
急诊早期NT-proBNP检测是否可以预警ACS患者院内MACE,其与GRACE、PURSUIT和HEART危险评分预测价值的比较,以及危险评分联合NT-proBNP后预测价值的变化,均鲜见相关报道。本研究旨在验证急诊早期NT-proBNP水平与院内主要不良心血管事件的相关性和独立预测性,进一步探讨其对院内MACE的预警价值并与传统危险评分和联合NT-proBNP后...
Practice guidelines for patients with ST-segment elevation and non-ST-segment elevation acute coronary syndrome (NSTE-ACS) have changed in response to evidence from randomized trials, which showed a clear positive outcome from pharmacologic and interventional treatments. An analysis of data from the ...
Follow guidelines according to the ANTITHROMBOTIC THERAPY ORDER FORM. iv. Platelet IIB/IIIA receptor antagonists are generally not indicated for these patients. 5 v. vi. vii. viii. ix. x. Medical therapy with beta-blockers is indicated to achieve a target heart rate of less than 60 bpm. ...
2002. /clinical/guidelines/unstable/unstable.pdf.未有高危表现的病人未有高危表现的病人低到中危病人没有血管再通术的禁忌症低到中危病人没有血管再通术的禁忌症12ongoing evaluation in an early conservative strategyrecurrent symptoms/ischemiaheart failure 7、serious arrhythmiapatient stabilizesef .40stress test...
RCAaccountedfor49%,LADaccountedfor49%.Thesinglebranchlesionsaccountedfor74.5%,threebranchlesionsaccountedfor9.8%,twobranchlesionsaccountedfor15.7%.ConclusionMostofACSpatientstreatwithPCIoperation,theD2Btimehasnotyetreachedthenewguidelines.InCoronaryarterydisease,LCAandRCAaremorecommon,andmoreappearasthesinglebranch...
lishedGuidelines/ACSHeart/heartpd.fhtm。 本文中观点仅为作者与委员所有,并不代表NACB和 IFCC官方观点。NACB是AACC的一个学术组织。 目录 Ñ.心力衰竭生物标志物分析概述 背景 Ò.生物标志物的分析 A.BNP和NT-proBNP的检测 1.BNP和NT-proBNP的参考值范围 2.BNP和NT-proBNP的生物学意义 3.BNP和NT-proBNP检...
Heart Failure-USB: Prediction and Progression No drug interventions Not Available Not Available recruiting NCT04175626 Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions No drug interventions Not Available Not Available active_not_recruitin...